Advancing knowledge of human development, developmental disabilities, and neurodegenerative diseases.
The National Institutes of Health-funded Alzheimer’s Biomarkers Consortium – Down Syndrome (ABC-DS), a large multi-center research initiative to find biomarkers to track Alzheimer’s disease in Down syndrome. The Waisman Center is part of this multi-site study across the United States and at University of Cambridge in England. As part of the study, the Waisman Center …
The development of brain imaging techniques has helped us understand emotion, intellectual and developmental disabilities, and neurodegenerative diseases in ways we could not before.
Our inability to derive the neuronal diversity that comprises the posterior central nervous system (pCNS) using human pluripotent stem cells (hPSCs) poses an impediment to understanding human neurodevelopment and disease in the hindbrain and spinal cord.
By Emily Leclerc, Waisman Science Writer One of Carl Ross’s favorite stories is actually an account of one of his failures. In the early 2000s Ross, the former managing director of Waisman Biomanufacturing (WB), was working to make a rhinovirus (the virus that is responsible for the common cold) that could be used to test …
Two UW-Madison undergraduate students who were awarded Sophomore Research Fellowships will be completing their research projects under Waisman Center advisors.
Structural pathologies, such as brain, are present at birth in Down syndrome (trisomy 21), reflecting embryonic origins that are generally associated with smaller organs or reduced growth.
English Por: Charlene N. Rivera Bonet Héctor Portillo se mudó a Wisconsin en el 2003 en busca de mejores opciones de atención médica para su hijo, quien tiene autismo. Después de más de una década de navegar el sistema de atención médica, se dio a la tarea de ayudar a las familias latinas con niños …
After more than a decade of navigating the health care system, he took it upon himself to help Latino families with kids with intellectual and developmental disabilities (IDD) find resources and supports, and navigate the healthcare system.
Children between 4-7 years old with a diagnosis of autism spectrum disorder are invited to participate in our new study about autism and ADHD. Families will be asked to visit the Waisman Center once per year for three years. During these visits, a parent completes a clinical interview and questionnaires about their child, while their …
White matter (WM) degeneration is a critical component of early Alzheimer's disease (AD) pathophysiology.
